INS and infection: A study carried out by Faassen et al. (1989) correlated the infection rate with the type of preservative included in the insulin formulation: 54% of patients (13 of 24) using m-cresol insulin formulations reported inflamed infusion sites, whereas only 19% (5 of 26) reported inflamed infusion sites using methylparaben-containing insulin [87].